Market Overview:
The global powder-based, needle-free injection system market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for minimally invasive surgeries and rising prevalence of chronic diseases. In addition, technological advancements in the field of powder-based, needle-free injection systems are also contributing to the growth of this market. Based on type, the global powder-based, needle-free injection system market is segmented into jet injectors, spring injectors, laser injectors and vibration injectors. Jet injectors are expected to account for a major share of this market during the forecast period owing to their high accuracy and efficiency as compared to other types of powder-based needles free injections systems.
Product Definition:
A powder-based, needle-free injection system is a delivery device that uses compressed gas to propel a powdered drug through the skin. This type of system is important because it is needle-free, which makes it less painful and reduces the risk of infection.
Jet:
Jet is a powdered injection system that uses compressed air to inject the drug into the vial. It's major advantages are cost-effectiveness and ease of use. Jet has been gaining popularity in countries such as India, China, and Brazil due to its needle-free feature which makes it safer for patients suffering from needle phobia or allergy.
Spring:
The global spring and it’s usage in the powder-based, needle-free injection system market size was valued at USD 6.5 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2019 to 2023.
Application Insights:
The general surgeries segment dominated the global market in 2017. The growing geriatric population and rising number of general surgeries are some of the factors driving this segment. According to a study published by the National Center for Biotechnology Information, it is estimated that around 250 million people aged 60 years or above were registered globally in 2015, while it is believed that there could be as many as 500 million older adults who might not be registered. This increasing geriatric population prone to various diseases and conditions will boost product demand over the forecast period.
Cardiovascular Surgeries is another prominent application where powder-based, needle-free injection systems are used owing to their ability to deliver drugs precisely at desired locations within the heart without causing any damage to surrounding tissues or organs due largely in part due their smaller size they can get past even tough barriers such as blood vessels & tendons with ease thus making them highly preferred over other types of injections for use during cardiovascular surgeries among others.
Regional Analysis:
North America dominated the global market in 2017 owing to factors such as increasing geriatric population, high prevalence of chronic diseases, and rising awareness about advanced medical technologies. Moreover, an increase in the number of surgical procedures is also expected to drive this regional market over the forecast period. In addition, a rise in preference for minimally invasive surgeries is also anticipated to propel growth during the forecast period.
Asia Pacific region is expected to grow at a lucrative rate over the forecast period due to factors such as improving healthcare infrastructure and growing target population base.
Growth Factors:
- Increasing demand for needle-free injection systems owing to their benefits over traditional injections
- Rising prevalence of chronic diseases that require regular injections for treatment, such as diabetes and cancer
- Technological advancements in the design and development of needle-free injection systems that improve efficacy and safety
- Growing awareness about the benefits of needle-free injection systems among healthcare professionals and patients alike
- Increasing demand for self-injection devices, especially in developed countries where there is a growing trend towards home healthcare
Scope Of The Report
Report Attributes
Report Details
Report Title
Powder-based, Needle-free Injection System Market Research Report
By Type
Jet, Spring, Laser, Vibration
By Application
Cardiovascular Surgeries, General Surgeries, Gynecological Surgeries, Orthopedic Surgeries, Ophthalmic Surgeries, Other
By Companies
ANTARES PHARMA, INC., ENDO INTERNATIONAL PLC, PHARMAJET, INC., INOVIO PHARMACEUTICALS, INC., MEDICAL INTERNATIONAL TECHNOLOGY, INC., MEDICAL INTERNATIONAL TECHNOLOGY, INC., NATIONAL MEDICAL PRODUCTS, INC., VALERITAS, INC., EUROPEAN PHARMA GROUP, PENJECT CORPORATION
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Powder-based, Needle-free Injection System Market Report Segments:
The global Powder-based, Needle-free Injection System market is segmented on the basis of:
Types
Jet, Spring, Laser, Vibration
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular Surgeries, General Surgeries, Gynecological Surgeries, Orthopedic Surgeries, Ophthalmic Surgeries, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ANTARES PHARMA, INC.
- ENDO INTERNATIONAL PLC
- PHARMAJET, INC.
- INOVIO PHARMACEUTICALS, INC.
- MEDICAL INTERNATIONAL TECHNOLOGY, INC.
- MEDICAL INTERNATIONAL TECHNOLOGY, INC.
- NATIONAL MEDICAL PRODUCTS, INC.
- VALERITAS, INC.
- EUROPEAN PHARMA GROUP
- PENJECT CORPORATION
Highlights of The Powder-based, Needle-free Injection System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Jet
- Spring
- Laser
- Vibration
- By Application:
- Cardiovascular Surgeries
- General Surgeries
- Gynecological Surgeries
- Orthopedic Surgeries
- Ophthalmic Surgeries
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Powder-based, Needle-free Injection System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Powder-based, needle-free injection systems are a type of medication delivery system that uses a powder to form the medication and then injects it into the patient's body using a needle. This system is less likely to cause infection than other types of injection systems, and it is also easier for patients to use.
Some of the major players in the powder-based, needle-free injection system market are ANTARES PHARMA, INC., ENDO INTERNATIONAL PLC, PHARMAJET, INC., INOVIO PHARMACEUTICALS, INC., MEDICAL INTERNATIONAL TECHNOLOGY, INC., MEDICAL INTERNATIONAL TECHNOLOGY, INC., NATIONAL MEDICAL PRODUCTS, INC., VALERITAS, INC., EUROPEAN PHARMA GROUP, PENJECT CORPORATION.
The powder-based, needle-free injection system market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Powder-based, Needle-free Injection System Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Powder-based, Needle-free Injection System Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Powder-based, Needle-free Injection System Market - Supply Chain
4.5. Global Powder-based, Needle-free Injection System Market Forecast
4.5.1. Powder-based, Needle-free Injection System Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Powder-based, Needle-free Injection System Market Size (000 Units) and Y-o-Y Growth
4.5.3. Powder-based, Needle-free Injection System Market Absolute $ Opportunity
5. Global Powder-based, Needle-free Injection System Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Powder-based, Needle-free Injection System Market Size and Volume Forecast by Type
5.3.1. Jet
5.3.2. Spring
5.3.3. Laser
5.3.4. Vibration
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Powder-based, Needle-free Injection System Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Powder-based, Needle-free Injection System Market Size and Volume Forecast by Application
6.3.1. Cardiovascular Surgeries
6.3.2. General Surgeries
6.3.3. Gynecological Surgeries
6.3.4. Orthopedic Surgeries
6.3.5. Ophthalmic Surgeries
6.3.6. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Powder-based, Needle-free Injection System Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Powder-based, Needle-free Injection System Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Powder-based, Needle-free Injection System Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Powder-based, Needle-free Injection System Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Powder-based, Needle-free Injection System Demand Share Forecast, 2019-2029
9. North America Powder-based, Needle-free Injection System Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Powder-based, Needle-free Injection System Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Powder-based, Needle-free Injection System Market Size and Volume Forecast by Application
9.4.1. Cardiovascular Surgeries
9.4.2. General Surgeries
9.4.3. Gynecological Surgeries
9.4.4. Orthopedic Surgeries
9.4.5. Ophthalmic Surgeries
9.4.6. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Powder-based, Needle-free Injection System Market Size and Volume Forecast by Type
9.7.1. Jet
9.7.2. Spring
9.7.3. Laser
9.7.4. Vibration
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Powder-based, Needle-free Injection System Demand Share Forecast, 2019-2029
10. Latin America Powder-based, Needle-free Injection System Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Powder-based, Needle-free Injection System Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Powder-based, Needle-free Injection System Market Size and Volume Forecast by Application
10.4.1. Cardiovascular Surgeries
10.4.2. General Surgeries
10.4.3. Gynecological Surgeries
10.4.4. Orthopedic Surgeries
10.4.5. Ophthalmic Surgeries
10.4.6. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Powder-based, Needle-free Injection System Market Size and Volume Forecast by Type
10.7.1. Jet
10.7.2. Spring
10.7.3. Laser
10.7.4. Vibration
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Powder-based, Needle-free Injection System Demand Share Forecast, 2019-2029
11. Europe Powder-based, Needle-free Injection System Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Powder-based, Needle-free Injection System Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Powder-based, Needle-free Injection System Market Size and Volume Forecast by Application
11.4.1. Cardiovascular Surgeries
11.4.2. General Surgeries
11.4.3. Gynecological Surgeries
11.4.4. Orthopedic Surgeries
11.4.5. Ophthalmic Surgeries
11.4.6. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Powder-based, Neele-free Injection System Market Size and Volume Forecast by Type
11.7.1. Jet
11.7.2. Spring
11.7.3. Laser
11.7.4. Vibration
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Powder-based, Needle-free Injection System Demand Share, 2019-2029
12. Asia Pacific Powder-based, Needle-free Injection System Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Powder-based, Needle-free Injection System Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Powder-based, Needle-free Injection System Market Size and Volume Forecast by Application
12.4.1. Cardiovascular Surgeries
12.4.2. General Surgeries
12.4.3. Gynecological Surgeries
12.4.4. Orthopedic Surgeries
12.4.5. Ophthalmic Surgeries
12.4.6. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Powder-based, Needle-free Injection System Market Size and Volume Forecast by Type
12.7.1. Jet
12.7.2. Spring
12.7.3. Laser
12.7.4. Vibration
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Powder-based, Needle-free Injection System Demand Share, 2019-2029
13. Middle East & Africa Powder-based, Needle-free Injection System Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Powder-based, Needle-free Injection System Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Powder-based, Needle-free Injection System Market Size and Volume Forecast by Application
13.4.1. Cardiovascular Surgeries
13.4.2. General Surgeries
13.4.3. Gynecological Surgeries
13.4.4. Orthopedic Surgeries
13.4.5. Ophthalmic Surgeries
13.4.6. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Powder-based, Needle-free Injection System Market Size and Volume Forecast by Type
13.7.1. Jet
13.7.2. Spring
13.7.3. Laser
13.7.4. Vibration
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Powder-based, Needle-free Injection System Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Powder-based, Needle-free Injection System Market: Market Share Analysis
14.2. Powder-based, Needle-free Injection System Distributors and Customers
14.3. Powder-based, Needle-free Injection System Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ANTARES PHARMA, INC.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ENDO INTERNATIONAL PLC
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. PHARMAJET, INC.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. INOVIO PHARMACEUTICALS, INC.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. MEDICAL INTERNATIONAL TECHNOLOGY, INC.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MEDICAL INTERNATIONAL TECHNOLOGY, INC.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. NATIONAL MEDICAL PRODUCTS, INC.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. VALERITAS, INC.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. EUROPEAN PHARMA GROUP
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. PENJECT CORPORATION
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
